...
首页> 外文期刊>Cancer chemotherapy and pharmacology. >Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer
【24h】

Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer

机译:异环磷酰胺联合卡铂和依托泊苷治疗小细胞肺癌的疗效和安全性

获取原文
获取原文并翻译 | 示例

摘要

Ifosfamide, a potent alkylating agent, is rarely incorporated into small cell lung cancer (SCLC) treatment. The aim of this study was to assess the efficacy and safety of ifosfamide in combination with carboplatin and etoposide (ICE) in previously untreated patients with SCLC.
机译:异环磷酰胺(一种有效的烷基化剂)很少掺入小细胞肺癌(SCLC)治疗中。这项研究的目的是评估异环磷酰胺联合卡铂和依托泊苷(ICE)在先前未经治疗的SCLC患者中的疗效和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号